139 related articles for article (PubMed ID: 16014826)
1. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali.
Tapia MD; Sow SO; Medina-Moreno S; Lim Y; Pasetti MF; Kotloff K; Levine MM
Am J Trop Med Hyg; 2005 Jul; 73(1):26-31. PubMed ID: 16014826
[TBL] [Abstract][Full Text] [Related]
2. Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk.
Mandomando IM; Naniche D; Pasetti MF; Vallès X; Cuberos L; Nhacolo A; Kotloff KL; Martins H; Levine MM; Alonso P
Am J Trop Med Hyg; 2008 Nov; 79(5):787-92. PubMed ID: 18981523
[TBL] [Abstract][Full Text] [Related]
3. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
Cohen BJ; Doblas D; Andrews N
Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
[TBL] [Abstract][Full Text] [Related]
4. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
[TBL] [Abstract][Full Text] [Related]
5. [Age-related loss of maternal antibodies against measles in children in La Plata].
del Buono MB; Vaschetti P; Iannicelli J; Silber R
Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
[TBL] [Abstract][Full Text] [Related]
6. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
[TBL] [Abstract][Full Text] [Related]
7. Immune response to measles vaccine in 6 month old infants in Papua New Guinea.
Kurubi J; Vince J; Ripa P; Tefuarani N; Riddell M; Duke T
Trop Med Int Health; 2009 Feb; 14(2):167-73. PubMed ID: 19171008
[TBL] [Abstract][Full Text] [Related]
8. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age.
Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF
Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229
[TBL] [Abstract][Full Text] [Related]
10. Sero-response to measles vaccination at 12 months of age in Saudi infants in Qassim Province.
Khalil MK; Nadrah HM; Al-Yahia OA; Al-Saigul AM
Saudi Med J; 2008 Jul; 29(7):1009-13. PubMed ID: 18626531
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
[TBL] [Abstract][Full Text] [Related]
12. Decay of maternally derived measles antibody in central Turkey.
Metintaş S; Akgün Y; Arslantaş D; Kalyoncu C; Uçar B
Public Health; 2002 Jan; 116(1):50-4. PubMed ID: 11896637
[TBL] [Abstract][Full Text] [Related]
13. Duration of maternally derived antibody against measles: a seroepidemiological study of infants aged under 8 months in Qinghai, China.
Zhang X; Shirayama Y; Zhang Y; Ba W; Ikeda N; Mori R; Shibuya K
Vaccine; 2012 Jan; 30(4):752-7. PubMed ID: 22133513
[TBL] [Abstract][Full Text] [Related]
14. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.
Cohen BJ; Parry RP; Doblas D; Samuel D; Warrener L; Andrews N; Brown D
J Virol Methods; 2006 Feb; 131(2):209-12. PubMed ID: 16188328
[TBL] [Abstract][Full Text] [Related]
15. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.
Sabin AB; Flores Arechiga A; Fernández de Castro J; Albrecht P; Sever JL; Shekarchi I
JAMA; 1984 May; 251(18):2363-71. PubMed ID: 6368888
[TBL] [Abstract][Full Text] [Related]
16. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination.
Bertley FM; Ibrahim SA; Libman M; Ward BJ
Vaccine; 2004 Dec; 23(4):444-9. PubMed ID: 15530692
[TBL] [Abstract][Full Text] [Related]
17. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
[TBL] [Abstract][Full Text] [Related]
18. [Levels of transition on maternal transferred measles antibody in infants in 3 cities in China].
Xu GZ; Ma R; Xu HJ; Ma YH; Dong HJ; Li Y; Hu FX; Ni HX; Bian GL; Liang Y; Liu LZ; Zhou SY; Huai QJ; Han XY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Nov; 29(11):1074-7. PubMed ID: 19173926
[TBL] [Abstract][Full Text] [Related]
19. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
Kong J; Guo SH; Ze WY
Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
